BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17673427)

  • 1. 18F-FDG PET in planning radiation treatment of non-small cell lung cancer: where exactly is the tumor?
    Dahele MR; Ung YC
    J Nucl Med; 2007 Aug; 48(8):1402; author reply 1403. PubMed ID: 17673427
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
    Nestle U; Kremp S; Grosu AL
    Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic threshold for radiation target volume by PET/CT.
    Wong CY; Mahajan P; Yan D
    J Nucl Med; 2007 May; 48(5):849; author reply 847. PubMed ID: 17475975
    [No Abstract]   [Full Text] [Related]  

  • 4. PET and PET-CT in radiation treatment planning for lung cancer.
    Aristei C; Falcinelli L; Palumbo B; Tarducci R
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):571-84. PubMed ID: 20397922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
    J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer.
    Macmanus M; D'Costa I; Everitt S; Andrews J; Ackerly T; Binns D; Lau E; Ball D; Weih L; Hicks RJ
    Australas Radiol; 2007 Aug; 51(4):386-93. PubMed ID: 17635480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing short-term effects and costs at an early stage of innovation: the use of positron emission tomography on radiotherapy treatment decision making.
    Remonnay R; Morelle M; Pommier P; Giammarile F; Carrère MO
    Int J Technol Assess Health Care; 2008; 24(2):212-20. PubMed ID: 18400125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer.
    Bradley JD; Perez CA; Dehdashti F; Siegel BA
    J Nucl Med; 2004 Jan; 45 Suppl 1():96S-101S. PubMed ID: 14736840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
    Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
    Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-of-the-art lung cancer radiation therapy.
    Belderbos J; Sonke JJ
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1353-63. PubMed ID: 19827995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
    Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical review of PET-CT for radiotherapy planning in lung cancer.
    Senan S; De Ruysscher D
    Crit Rev Oncol Hematol; 2005 Dec; 56(3):345-51. PubMed ID: 15990331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET scans in radiotherapy planning of lung cancer.
    De Ruysscher D; Kirsch CM
    Radiother Oncol; 2010 Sep; 96(3):335-8. PubMed ID: 20656364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of PET/CT for staging and radiation therapy planning in patients with non-small cell lung cancer.
    Mac Manus MP
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):510-20. PubMed ID: 20927018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommendations for the use of PET-CT with 18F-FDG in radiotherapy planning].
    García Vicente AM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):364. PubMed ID: 23063325
    [No Abstract]   [Full Text] [Related]  

  • 17. Personnel radiation dose considerations in the use of an integrated PET-CT scanner for radiotherapy treatment planning.
    Carson KJ; Young VA; Cosgrove VP; Jarritt PH; Hounsell AR
    Br J Radiol; 2009 Nov; 82(983):946-9. PubMed ID: 19332513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of PET-CT data for radiotherapy planning: what are we looking for?
    Chiti A; Kirienko M; Grégoire V
    Radiother Oncol; 2010 Sep; 96(3):277-9. PubMed ID: 20727607
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of 18F-FDG PET in oncology: clinical and resource implications.
    Al-Nahhas A; Win Z; Singh A; Khan S; Al-Sayed Y
    Nucl Med Rev Cent East Eur; 2006; 9(1):1-5. PubMed ID: 16791796
    [No Abstract]   [Full Text] [Related]  

  • 20. Lung tumor segmentation in PET images using graph cuts.
    Ballangan C; Wang X; Fulham M; Eberl S; Feng DD
    Comput Methods Programs Biomed; 2013 Mar; 109(3):260-8. PubMed ID: 23146420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.